"I don't see any reason why the drug would be limited to up to 6 hrs post TBI in a post trial clinical setting"
Remember the big thing is to reduce/stop the "second swelling" event.
nnz2566 may well help tbi sufferers later, but at the moment the trials are targeted to see if it helps with this major happening. It's also much easier to demonstrate drug efficacy.
Cheers
The Case for Yes, page-27
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.76 |
Change
-0.210(1.05%) |
Mkt cap ! $2.523B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.96 | $19.69 | $3.056M | 154.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 209 | $19.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.77 | 471 | 16 |
View Market Depth
| Last trade - 15.30pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |